Compare OVID & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVID | ALTI |
|---|---|---|
| Founded | 2014 | 2020 |
| Country | United States | United States |
| Employees | N/A | 490 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.5M | 492.8M |
| IPO Year | 2017 | 2021 |
| Metric | OVID | ALTI |
|---|---|---|
| Price | $2.69 | $3.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $4.60 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 164.7K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.90 | ★ 41.11 |
| EPS | ★ N/A | N/A |
| Revenue | $7,252,000.00 | ★ $254,956,000.00 |
| Revenue This Year | N/A | $18.06 |
| Revenue Next Year | $19.34 | $10.71 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1181.27 | 23.21 |
| 52 Week Low | $1.12 | $2.75 |
| 52 Week High | $3.11 | $5.45 |
| Indicator | OVID | ALTI |
|---|---|---|
| Relative Strength Index (RSI) | 46.31 | 38.22 |
| Support Level | $2.60 | $3.23 |
| Resistance Level | $2.77 | $3.97 |
| Average True Range (ATR) | 0.13 | 0.22 |
| MACD | -0.03 | -0.10 |
| Stochastic Oscillator | 10.29 | 29.03 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.